This same approach is a focus of Alzheimer’s disease, where PGC-1α can reduce β-secretase thereby decreasing amyloid-β and the associated neuronal and cognitive loss [56]. The gene discussed is PPARGC1A; the disease is early-onset autosomal dominant Alzheimer disease.